Development and validation of reversed-phase HPLC method for simultaneous estimation of atorvastatin calcium and telmisartan in tablet dosage form

International Journal of PharmTech Research

Volumn 2, Issue 1, 2010, Pages 463-470

  Suresh Kumar, G V ^a   Rajendraprasad, Y ^b   Chandrashekar, S M ^a  

^a St Johns Pharmacy College   (India)

^b ANDHRA UNIVERSITY   (India)

Author keywords

Assay; Atorvastatin calcium; RP HPLC; Telmisartan; Validation

Indexed keywords

ACETIC ACID; ACETONITRILE; AMMONIUM ACETATE; ATORVASTATIN; TELMISARTAN;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; FLOW RATE; PH MEASUREMENT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TABLET FORMULATION; VALIDATION STUDY;

EID: 77953403949     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lea AP, McTavish D. Atorvastatin: a review of its pharmacology and therapeutic potential in the management of hyperlipidaemias. Drugs 53 (1997) 828-847.
2. Ramsay.L.E, G Dennis Johnston, Graham A MacGregor, Lucilla Poston, British Hypertension Society guidelines for hypertension management 1999 Brit. Med. J. 319 (1999) 630-635.
3. Mc Clellan KJ, Markham A. Telmisartan. Angiotensin II Antagonists in the Treatment of Hypertension: More Similarities Than Differences, Drugs. 56 (1998) 1039-1044.
4. Anon Pharmacy and Therapeutics Review - Telmisartan. The Formulary, Jan (1999) 13-18.
5. Benson SC, Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension 43 (2004) 993-1002.
6. Erfinder, 2004. The pharmaceutical combination for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases WO2004/062557 A2.
7. William W. Bullen, Ronald A. Miller, Roger N. Hayes Development and validation of a high-performance liquid chromatography tandem mass spectrometry assay for atorvastatin, ortho-hydroxy atorvastatin, and para-hydroxy atorvastatin in human, dog, and rat plasma, J. Am. Soc. Mass Spectrom 10 (1999) 55-66.
8. Mohammed Jemal, Zheng Ouyang, Bang-Chi Chen, Deborah Teitz Quantitation of the acid and lactone forms of atorvastatin and its biotransformation products in human serum by high-performance liquid Rapid commun. Mass spectrum, chromatography with electrospray tandem mass spectrometry, 13 (1999) 1003-1015.
9. Sidika Ertürk, Arma an Önal, Sevil Müge Çetin (2003). Analytical methods for the quantitative determination of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in biological samples, J. of Chrom. B 793 (2003) 193-205.
10. Xiu-Sheng Miao, Chris D. Metcalfe Determination of cholesterol-lowering statin drugs in aqueous samples using liquid chromatography-electrospray ionization tandem mass spectrometry, J. of Chrom. A 998 (2003) 133-14.
11. Xiu-Sheng Miao, Chris D. Metcalfe Determination of pharmaceuticals in aqueous samples using positive and negative voltage switching microbore liquid chromatography/electrospray ionization tandem mass spectrometry, J of Mass Spectro., 38 (2003) 27-34.
12. A. Mohammadi, N. Rezanour, M. Ansari Dogaheh, F. Ghorbani Bidkorbeh, M. Hashem, R.B. Walker A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets, J. of Chrom. B. 846 (2007) 215-22.
13. Sidika Ertürk, Esra Sevinç Akta , Lale Ersoy, Samiye Fiçicio lu, An HPLC method for the determination of atorvastatin and its impurities in bulk drug and tablets Journal of Pharma. and Biomed. Anal. 33 (2003) 1017-1023.
14. A.A. Kadav, D.N. Vora Stability indicating UPLC method for simultaneous determination of atorvastatin, fenofibrate and their degradation products in tablets, J. of Pharma. and Biomed. Anal. 48 (2008)120-126.
15. Maotian Xu, Junfeng Song, Yaodong Liang, Rapid determination of telmisartan in pharmaceutical preparations and serum by linear sweep polarography, Journal of Pharma. and Biomed. Anal. 34 (2004) 681-687.
16. Robert E. Dinnebier, Peter Sieger, Herbert Nar, Kenneth Shankland, William I. F. David, structural characterization of three crystalline modifications of telmisartan by single crystal and high-resolution X-ray powder diffraction, J of Pharma. Sci., 89 (2000)1465-1479.
17. RP-HPLC determination of Telmisartan in tablet dosage forms. Palled MS, Rajesh PM, Chatter M, Bhat AR,. Indian J Pharm Sci 67 (2005) 108-10.
18. Rao KV, Vijaya Kumari K, Bhanuprakash I, Prabhakar G, Begum J. Determination of ramipril in pharmaceutical dosage forms by reversed-phase liquid chromatography. Asian J Chem 18 (2006) 788-92.
19. Kumar MV, Muley PR. Stability indicating RP-HPLC method for determination of Telmisartan in solid dosage forms. Indian Pharmacist 4 (2005) 69-72.
20. ICH-Q2B Validation of Analytical Procedures: 1996. Methodology International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva, Switzerland.